首页> 外文会议>日本化学会春季年会講演予稿集 >Design, Synthesis and RNase H activity of Hemi-Gapmer Type Peptide Ribonucleic Acid (PRNA)-DNA chimeras for the RNase H mediated catalytic oligonucleotide therapeutics
【24h】

Design, Synthesis and RNase H activity of Hemi-Gapmer Type Peptide Ribonucleic Acid (PRNA)-DNA chimeras for the RNase H mediated catalytic oligonucleotide therapeutics

机译:半介距型肽核糖核糖核酸(PRNA)-DNA嵌合催化寡核苷酸治疗剂的设计,合成和RNase H活性

获取原文

摘要

Oligonucleotide therapeutics has received much attention as a promising candidate for next generation molecular targeted drugs. Despite the very attractive features, there still remain a major issue; i.e., the expression of therapeutic effect on non-target normal cells, called off-target effects [1].
机译:寡核苷酸治疗剂已作为下一代分子靶向药物的有希望的候选者获得了很多关注。尽管功能非常有吸引力,但仍然存在一个主要问题;即,表达对非靶正常细胞的治疗作用,称为偏离目标效果[1]。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号